COVID-19

Comparison of fluvoxamine versus placebo

Comparison of fluvoxamine versus placebo

The Doctors of the Therapeutic Clinic of the School of Medicine of the National and Kapodistrian University of Athens Theodora Psaltopoulou, Rodanthi Eleni Syrigou, Yannis Danasis, Panos Malandrakis, and Thanos Dimopoulos (Rector EKPA) summarize the data of the recent publication by Matthew W. McCarthy and colleagues in the prestigious scientific JAMA review comparing the efficacy of fluvoxamine versus placebo on time to recovery in outpatients with mild to moderate Covid-19 disease.

The Therapeutic Interventions and Vaccines Platform (ACTIV-6) randomized clinical trial was designed to test drugs approved for other conditions in outpatients with mild to moderate Covid-19 disease. Overall, patients were at least 30 years of age with a confirmed positive SARS-CoV-2 test and experienced 2 or more symptoms of acute Covid-19 infection for 7 or fewer days from August 6, 2021 through May 27, 2022; at 91 centers in the United States. Participants were randomized to receive 50 mg of fluvoxamine twice daily for 10 days or placebo for the corresponding days. Fluvoxamine is an antidepressant drug in the class of selective serotonin reuptake inhibitors (SSRIs).

The primary endpoint was time to recovery, i.e. time to 3 consecutive symptom-free days. Among secondary endpoints, the composite endpoint including hospitalization, emergency department visit, and death by day 28 of follow-up is of interest.

Among the 1331 randomized participants (median age 47 years), 57% were women and 67% reported receiving at least 2 doses of SARS-CoV-2 vaccine. 1288 patients completed the clinical trial (674 in the fluvoxamine group and 614 in the placebo group). The median time to recovery was 12 days in the fluvoxamine group and 13 days in the placebo group. For the composite secondary endpoint, 26 participants (3.9%) in the fluvoxamine group were hospitalized, had an urgent emergency department visit, or died compared with 23 participants (3.8%) in the placebo group. One of the participants in the fluvoxamine group and 2 of the participants in the placebo group were hospitalized. No deaths occurred during the study. Adverse events were uncommon for both groups of patients.

Source: https://hellas.postsen.com/coronavirus/245156/Comparison-of-fluvoxamine-versus-placebo.html

National and Kapodistrian University of Athens ranks first in Greece and Cyprus – Times Higher Education University Impact Rankings 2025 and US News Global University Rankings 2025-2026 announced

National and Kapodistrian University of Athens ranks first in Greece and Cyprus – Times Higher Education University Impact Rankings 2025 and US News Global University Rankings 2025-2026 announced

US News & World Report Media Company has recently published the results of its Best Global Universities Rankings for 2025-2026. In this 11th consecutive annual edition of the US News Best Global Universities Rankings, the National and Kapodistrian University of Athens placed 1st among Greek and Cypriot Universities and 216th worldwide. Aristotle University of Thessaloniki […]

Once again, top-scoring candidates choose the University of Athens

Once again, top-scoring candidates choose the University of Athens

It is a day of joy for many candidates who have recently sat the nationwide examinations for admission to Greece’s Higher Educational Institutions. Among this year’s top achievers—those scoring over 19,000 points—a significant number have once again set their sights on enrolling in the National and Kapodistrian University of Athens (NKUA). One of the highest […]

Renovated ‘New Chemistry Laboratory Building’ opens officially – School of Education, Library of the Department of Economics

Renovated ‘New Chemistry Laboratory Building’ opens officially – School of Education, Library of the Department of Economics

In a particularly symbolic and emotional opening ceremony, the renovated ‘New Chemistry Laboratory Building’ was officially handed over to the academic community of the National and Kapodistrian University of Athens. This historic building lies at the heart of Athens, surrounded on three sides by Mavromichali, Navarinou, and Charilaou Trikoupi streets. With the completion of the […]

Prof. Dr. Xenofon Baraliakos, Medical Director of the Rheumazentrum Ruhrgebiet, Herne, and Doctor Honoris Causa of the School of Medicine of the University of Athens, is the new president of the European Alliance of Associations for Rheumatology (EULAR)

Prof. Dr. Xenofon Baraliakos, Medical Director of the Rheumazentrum Ruhrgebiet, Herne, and Doctor Honoris Causa of the School of Medicine of the University of Athens, is the new president of the European Alliance of Associations for Rheumatology (EULAR)

Prof. Dr. Xenofon Baraliakos, Medical Director of the Rheumazentrum Ruhrgebiet, Herne, and Professor for Internal Medicine and Rheumatology at the Ruhr University Bochum, Germany, is the new president of the European Alliance of Associations for Rheumatology (EULAR). During his two-year term, he plans to implement a number of measures aimed at further improving patient care […]

Alpha TV: NKUA ranks among the top 100 Universities in the world

Alpha TV: NKUA ranks among the top 100 Universities in the world

Rectors and Vice-Rectors from 54 Universities in Europe met at the historic main building of the University of Athens to participate in the 35th General Assembly of the UNICA Network of Universities from the Capitals of Europe, which took place for the first time in Greece earlier this month. At the same time, the University […]

The 35th General Assembly of the Universities from the Capitals of Europe (UNICA) closes at NKUA with great success and participation from across the continent

The 35th General Assembly of the Universities from the Capitals of Europe (UNICA) closes at NKUA with great success and participation from across the continent

With the symbolic strength of Athens’ scholarly tradition encompassing contemporary academic collaboration, the 35th General Assembly of the Universities from the Capitals of Europe (UNICA) closed at the historic main building of the University of Athens. The proceedings began on Thursday, 19 June, with the UNICA Administrative General Assembly. The meeting, held in a hybrid […]

MA “Philosophy”: Call for applications for the academic year 2025-2026

MA “Philosophy”: Call for applications for the academic year 2025-2026

The Department of Philosophy of the National and Kapodistrian University of Athens invites those interested, to apply for: *one of the -up to 50- postgraduate positions of the MA “Philosophy”, specialization: “History of Philosophy and Ideas (Greek Philosophy)” * General Information ➢The classes are held online ➢The program grants the Postgraduate Degree Master of Arts in “Philosophy”, in the specialization: “History of Philosophy and Ideas (Greek Philosophy)“ ➢Starting date : October 2025 ➢Language of instruction : English ➢Number of courses : 6 courses & a short master thesis ➢Duration : one year-intensive program (two semesters -winter & spring- and a summer term) ➢Credits : the program consists of 75 ECTS ➢Tuition fee : 850 € (EUR) per semester (each of the two installments is due in […]

University of Athens

The National and Kapodistrian University of Athens, which was inaugurated on May 3, 1837, was initially housed in a renovated Ottoman building on the northeastern side of the Acropolis. This building has since been restored and now functions as the University Museum. Originally named the "Othonian University," after Otto, the first king of Greece, it consisted of four academic departments and 52 students. As the first university of the newly established Greek state, as well as of the broader Balkan and Mediterranean region, it assumed an important socio-historical role, which was pivotal in the development of specific forms of knowledge and culture within the country.

Stay Connected

Follow hub.uoa.gr on Social Media

closebutton
Skip to content